Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Sales | 2,507,000 | 4,154,000 | 4,871,000 | 4,676,000 | 4,417,000 |
| Cost of Goods | 911,000 | 1,465,000 | 1,568,000 | 1,476,000 | 1,404,000 |
| Gross Profit | 1,596,000 | 2,689,000 | 3,303,000 | 3,200,000 | 3,013,000 |
| Operating Expenses | 2,170,000 | 2,197,000 | 2,329,000 | 2,320,000 | 2,258,000 |
| Operating Income | -574,000 | 492,000 | 974,000 | 880,000 | 755,000 |
| Other Income | -261,000 | 125,000 | 136,000 | 313,000 | -135,000 |
| Pre-tax Income | -835,000 | 617,000 | 1,110,000 | 1,193,000 | 620,000 |
| Income Tax | -346,000 | 193,000 | 256,000 | 328,000 | 116,000 |
| Net Income Continuous | -505,000 | 338,000 | 667,000 | 714,000 | 349,000 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 150,000 |
| Net Income | $-134,000 | $338,000 | $667,000 | $714,000 | $499,000 |
| EPS Basic Total Ops | -0.06 | 0.17 | 0.34 | 0.36 | 0.26 |
| EPS Basic Continuous Ops | -0.26 | 0.17 | 0.34 | 0.36 | 0.18 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | 0.08 |
| EPS Diluted Total Ops | -0.06 | 0.17 | 0.34 | 0.36 | 0.26 |
| EPS Diluted Continuous Ops | -0.24 | 0.17 | 0.33 | 0.36 | 0.18 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | 0.08 |
| EBITDA(a) | $-340,000 | $722,000 | $1,211,000 | $1,106,000 | $994,000 |